George Altman

• George Altman 25 Mar 2022 16:17 UTC

  2 points

  0 ∶ 0

  on: Mind En­hance­ment: A High Im­pact, High Ne­glect Cause Area?

  Great work! Looking forward to the cause profile

Cause pro­file: Cog­ni­tive En­hance­ment Re­search

• George Altman 28 Mar 2022 11:02 UTC

  3 points

  0 ∶ 0

  in reply to: Inga’s comment on: Cause pro­file: Cog­ni­tive En­hance­ment Re­search

  Thanks for the useful links! I think some kind of database with effect sizes, who it works for etc would be really useful. Prioritising between different cognitive enhancers for future research is one of the recommendations I would be excited to see. Avoiding things is something I didn’t consider in much depth but it would be interesting to look into.

• George Altman 12 Apr 2022 14:45 UTC

  4 points

  0 ∶ 0

  in reply to: nathanhb’s comment on: Cause pro­file: Cog­ni­tive En­hance­ment Re­search

  Thanks for your comment. It’s interesting to hear about the similarities between genetic and pharmacological enhancement, such as funding and legal restrictions. The interaction of AGI timelines and pharmacological enhancement is one of the areas where I am least certain. Theoretically, enhancement could speed up the development of AGI and alignment. I’m unsure about the balance of risks and benefits here.